America
New treatment offers hope for treating diabetes, MS
New York, March 5
Researchers have developed a novel and safe treatment for autoimmune diseases including Type-1 diabetes and multiple sclerosis (MS) that arise when the body's immune cells attack itself.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
12 hours ago
Indian American Pavan Davuluri Appointed Head of Windows and Surface Devices Teams by Microsoft
12 hours ago
The H-1B lottery will be held by USCIS, and initial registration is closed.
12 hours ago
On International Women's Day, Malabar Gold and Diamonds celebrates with the Indian Women's Club of Northshore, Illinois.
12 hours ago
Rights organizations unite to condemn the surge of Hindu supremacy in the US
14 hours ago
'Unacceptable, unwarranted': India again slams US' remarks on Arvind Kejriwal
14 hours ago
Kerala CPI-M legends' tombs vandalised in Kannur, probe launched
14 hours ago
The journey of Supreme Court and India’s fundamental rights has been a constant struggle: SG Tushar Mehta
15 hours ago
Mumbai doctors save micro-preemie baby born at 23 weeks weighing 620 grams
15 hours ago
New AI tool can predict fatal heart rhythm with 80 pc accuracy
15 hours ago
South Korea to bar intern doctors if they don't register for jobs
15 hours ago
Smart TV shipments drop 16 pc as premium TVs drive growth in India: Report
15 hours ago
New paper-based device to make on-spot glucose testing using smartphone
15 hours ago
Only 4 pc of Indian firms are 'mature' to tackle modern cyber attacks: Report